Maximizing returns in biotherapeutic investment: Financial considerations for expression systems

Picking the right expression system to produce your biotherapeutic can cost you more than just product quality and serious consideration of all factors is crucial. This decision will not only impact on quality and quantity of biotherapeutic produced, but also on the overall production cost-effectiveness of your process.

In this whitepaper, we examine the key factors you should be considering during expression system selection that will help you optimize resource allocation, reduce risk, and maximize the potential for commercial success.

Covering areas in:

• Balancing higher titers and diminishing returns
• Savings gained with stable pools in early-stage development
• The cost-yield equation
• Sustainability processes to optimize efficiency 

The CHOSOURCE Platform is available for research, clinical, diagnostic, and commercialization applications, including services, under specific licenses from Revvity.